Prion protein may play key role in progression of glioblastoma
Glioblastoma (GBM), one of the most aggressive types of brain cancer, is one of the greatest challenges for medicine, both ...
March 2025 Letter to Shareholders
VANCOUVER, Washington, March 18, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, ...
pharmaphorum5d
Trial of Jazz' cannabis drug in glioblastoma will start next year
If ARISTOCRAT is successful, Sativex could become one of the first additions to NHS treatment for glioblastoma patients since temozolomide chemotherapy in 2007. At the moment Jazz is directed its ...
CytoDyn Inc.: March 2025 Letter to Shareholders
Dear Shareholders, As envisioned, 2025 is unfolding to be an exciting year for CytoDyn Inc. ("CytoDyn" or the "Company"). On February 24, 2025 ...